Records 1 - 6
| Role of LRRK2 variant p.Gly2019Ser in patients with Parkinsonism.
The Indian journal of medical research 2020 Jun 151 (6): 592-597.
Sadhukhan Dipanwita, Biswas Arindam, Bhaduri Arunima, Sarkar Neelanjana, Biswas Atanu, Das Shyamal K, Banerjee Tapas K, Ray Kunal, Ray Jhar
| Different Contributions of CDKAL1, KIF21B, and LRRK2/MUC19 Polymorphisms to SAPHO Syndrome, Rheumatoid Arthritis, Ankylosing Spondylitis, and Seronegative Spondyloarthropathy.
Genetic testing and molecular biomarkers 2016 Dec .
Li Nan, Ma Junfen, Li Kai, Guo Changlong, Ming Lia
| High Frequency of GBA Gene Mutations in Dementia With Lewy Bodies Among Ashkenazi Jews.
JAMA neurology 2016 Oct .
Shiner Tamara, Mirelman Anat, Gana Weisz Mali, Bar-Shira Anat, Ash Elissa, Cialic Ron, Nevler Naomi, Gurevich Tanya, Bregman Noa, Orr-Urtreger Avi, Giladi N
| Association between early-onset Parkinson disease and 22q11.2 deletion syndrome: identification of a novel genetic form of Parkinson disease and its clinical implications.
JAMA neurology 2013 Nov 70 (11): 1359-66.
Butcher Nancy J, Kiehl Tim-Rasmus, Hazrati Lili-Naz, Chow Eva W C, Rogaeva Ekaterina, Lang Anthony E, Bassett Anne
| The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: clinical and demographic characteristics.
Neuroscience letters 2013 Jan .
Mabel GE, Virginia P, Paola CD, José PJ, Cecilia CM, Felix MM, Coro PR
| Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.
Neurology 2008 Feb 70 (7): 521-7.
Chen-Plotkin A S, Yuan W, Anderson C, McCarty Wood E, Hurtig H I, Clark C M, Miller B L, Lee V M-Y, Trojanowski J Q, Grossman M, Van Deerlin V